Association between steroid hormone receptor status and disease-free interval in breast cancer

J. C. Allegra; M. E. Lippman; R. Simon; E. B. Thompson; A. Barlock; L. Green; K. K. Huff; H. M. Do; S. C. Aitken; R. Warren

Association between steroid hormone receptor status and disease-free interval in breast cancer

J. C. Allegra, M. E. Lippman, R. Simon, E. B. Thompson, A. Barlock, L. Green, K. K. Huff, H. M. Do, S. C. Aitken, R. Warren

Medicine

Research output: Contribution to journal › Article › peer-review

105 Scopus citations

Abstract

The possibility of an association between steroid hormone receptor status and disease-free interval was examined in 292 patients with breast cancer. Estrogen receptor positivity was associated with a prolonged disease-free interval. This association was independent of age, menopausal status, tumor size, or nodal status. There was no association between the presence or absence of progesterone, androgen, or glucocorticoid receptor and disease-free interval.

Original language	English (US)
Pages (from-to)	1271-1277
Number of pages	7
Journal	Cancer Treatment Reports
Volume	63
Issue number	8
State	Published - Dec 1 1979

ASJC Scopus subject areas

Oncology
Cancer Research

Fingerprint Dive into the research topics of 'Association between steroid hormone receptor status and disease-free interval in breast cancer'. Together they form a unique fingerprint.

Cite this

Association between steroid hormone receptor status and disease-free interval in breast cancer. / Allegra, J. C.; Lippman, M. E.; Simon, R.; Thompson, E. B.; Barlock, A.; Green, L.; Huff, K. K.; Do, H. M.; Aitken, S. C.; Warren, R.

In: Cancer Treatment Reports, Vol. 63, No. 8, 01.12.1979, p. 1271-1277.

Research output: Contribution to journal › Article › peer-review

@article{bebae68237b9466eb8c6635834e485b4,

title = "Association between steroid hormone receptor status and disease-free interval in breast cancer",

abstract = "The possibility of an association between steroid hormone receptor status and disease-free interval was examined in 292 patients with breast cancer. Estrogen receptor positivity was associated with a prolonged disease-free interval. This association was independent of age, menopausal status, tumor size, or nodal status. There was no association between the presence or absence of progesterone, androgen, or glucocorticoid receptor and disease-free interval.",

author = "Allegra, {J. C.} and Lippman, {M. E.} and R. Simon and Thompson, {E. B.} and A. Barlock and L. Green and Huff, {K. K.} and Do, {H. M.} and Aitken, {S. C.} and R. Warren",

year = "1979",

month = dec,

day = "1",

language = "English (US)",

volume = "63",

pages = "1271--1277",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Association between steroid hormone receptor status and disease-free interval in breast cancer

AU - Allegra, J. C.

AU - Lippman, M. E.

AU - Simon, R.

AU - Thompson, E. B.

AU - Barlock, A.

AU - Green, L.

AU - Huff, K. K.

AU - Do, H. M.

AU - Aitken, S. C.

AU - Warren, R.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - The possibility of an association between steroid hormone receptor status and disease-free interval was examined in 292 patients with breast cancer. Estrogen receptor positivity was associated with a prolonged disease-free interval. This association was independent of age, menopausal status, tumor size, or nodal status. There was no association between the presence or absence of progesterone, androgen, or glucocorticoid receptor and disease-free interval.

AB - The possibility of an association between steroid hormone receptor status and disease-free interval was examined in 292 patients with breast cancer. Estrogen receptor positivity was associated with a prolonged disease-free interval. This association was independent of age, menopausal status, tumor size, or nodal status. There was no association between the presence or absence of progesterone, androgen, or glucocorticoid receptor and disease-free interval.

UR - http://www.scopus.com/inward/record.url?scp=0018595291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018595291&partnerID=8YFLogxK

M3 - Article

C2 - 476705

AN - SCOPUS:0018595291

VL - 63

SP - 1271

EP - 1277

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 8

ER -